JP2007507532A5 - - Google Patents

Download PDF

Info

Publication number
JP2007507532A5
JP2007507532A5 JP2006534173A JP2006534173A JP2007507532A5 JP 2007507532 A5 JP2007507532 A5 JP 2007507532A5 JP 2006534173 A JP2006534173 A JP 2006534173A JP 2006534173 A JP2006534173 A JP 2006534173A JP 2007507532 A5 JP2007507532 A5 JP 2007507532A5
Authority
JP
Japan
Prior art keywords
international
opioid receptor
documents cited
peptidic
pamphlet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006534173A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007507532A (ja
JP4976134B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/032479 external-priority patent/WO2005033073A2/en
Publication of JP2007507532A publication Critical patent/JP2007507532A/ja
Publication of JP2007507532A5 publication Critical patent/JP2007507532A5/ja
Application granted granted Critical
Publication of JP4976134B2 publication Critical patent/JP4976134B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006534173A 2003-10-01 2004-10-01 スピロ環複素環誘導体及びそれらを使用する方法 Expired - Fee Related JP4976134B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50786403P 2003-10-01 2003-10-01
US60/507,864 2003-10-01
PCT/US2004/032479 WO2005033073A2 (en) 2003-10-01 2004-10-01 Spirocyclic heterocyclic derivatives and methods of their use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011107724A Division JP2011201896A (ja) 2003-10-01 2011-05-13 スピロ環複素環誘導体及びそれらを使用する方法

Publications (3)

Publication Number Publication Date
JP2007507532A JP2007507532A (ja) 2007-03-29
JP2007507532A5 true JP2007507532A5 (https=) 2007-11-22
JP4976134B2 JP4976134B2 (ja) 2012-07-18

Family

ID=34421676

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006534173A Expired - Fee Related JP4976134B2 (ja) 2003-10-01 2004-10-01 スピロ環複素環誘導体及びそれらを使用する方法
JP2011107724A Pending JP2011201896A (ja) 2003-10-01 2011-05-13 スピロ環複素環誘導体及びそれらを使用する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011107724A Pending JP2011201896A (ja) 2003-10-01 2011-05-13 スピロ環複素環誘導体及びそれらを使用する方法

Country Status (13)

Country Link
US (6) US7338962B2 (https=)
EP (1) EP1675847B1 (https=)
JP (2) JP4976134B2 (https=)
KR (2) KR101255074B1 (https=)
CN (2) CN101921279A (https=)
AU (1) AU2004278414B2 (https=)
BR (1) BRPI0415165A (https=)
CA (1) CA2541014A1 (https=)
CO (1) CO5690640A2 (https=)
IL (2) IL174702A (https=)
NZ (3) NZ546834A (https=)
WO (1) WO2005033073A2 (https=)
ZA (1) ZA200603414B (https=)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1037880T3 (da) * 1997-12-11 2004-11-15 Janssen Pharmaceutica Nv Anilider som retinsyremimetika
NZ546834A (en) * 2003-10-01 2010-03-26 Adolor Corp Spirocyclic heterocyclic derivatives and methods of their use
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
AU2006284675A1 (en) 2005-09-01 2007-03-08 Janssen Pharmaceutica N.V. Novel benzopyran derivatives as potassium channel openers
WO2007027780A2 (en) * 2005-09-01 2007-03-08 Janssen Pharmaceutica N.V. Benzopyran and pyranopyridine derivatives as potassium channel openers
US7576207B2 (en) * 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
WO2007128782A1 (en) * 2006-05-05 2007-11-15 Boehringer Ingelheim International Gmbh Spiro- (tho) benzopyran-2, 4' -piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes
WO2008033299A2 (en) * 2006-09-12 2008-03-20 Adolor Corporation Use of n-containing spirocompounds for the enhancement of cognitive function
TWI425945B (zh) * 2007-05-28 2014-02-11 Seldar Pharma Inc 四氫異喹啉－１－酮衍生物或其鹽
UA100877C2 (ru) * 2008-01-30 2013-02-11 Сефалон, Інк. Замещенные спироциклические производные пиперидина как лиганды рецепторов гистамина-3 (h3)
EP2250176B1 (en) * 2008-01-30 2012-08-01 Cephalon, Inc. Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands
WO2009143299A1 (en) 2008-05-20 2009-11-26 Neurogesx, Inc. Hepatoprotectant acetaminophen mutual prodrugs
KR101923367B1 (ko) 2011-02-02 2018-12-04 버텍스 파마슈티칼스 인코포레이티드 이온 채널의 조절제로서의 피롤로피라진―스피로사이클릭 피페리딘 아미드
MX2013009393A (es) * 2011-02-18 2013-08-29 Vertex Pharma Piperidinamidas cromano-espirociclicas como moduladores de canales de iones.
CN103517910B (zh) 2011-03-14 2016-12-14 沃泰克斯药物股份有限公司 作为离子通道调节剂的吗啉-螺环哌啶酰胺
SI2688403T1 (sl) * 2011-03-23 2017-08-31 Trevena, Inc. Ligandi opioidnih receptorjev in metode uporabe in izdelave istega
CA2882038A1 (en) 2012-08-16 2014-02-20 Janssen Pharmaceutica Nv Substituted pyrazoles as n-type calcium channel blockers
JP6131414B2 (ja) 2012-08-21 2017-05-24 ヤンセン ファーマシューティカ エヌ．ベー． アリピプラゾールのハプテン及びイムノアッセイにおけるそれらの使用
JP6450314B2 (ja) 2012-08-21 2019-01-09 ヤンセン ファーマシューティカ エヌ．ベー． クエチアピンハプテンに対する抗体及びその使用
CA2882562C (en) 2012-08-21 2019-08-27 Eric Hryhorenko Antibodies to aripiprazole and use thereof
JP2015527365A (ja) 2012-08-21 2015-09-17 オルソ−クリニカル ダイアグノスティクス，インコーポレイティド パリペリドンに対する抗体及びその使用
JP6389176B2 (ja) 2012-08-21 2018-09-12 ヤンセン ファーマシューティカ エヌ．ベー． アリピプラゾールハプテンに対する抗体及びその使用
CA2882596C (en) 2012-08-21 2019-05-14 Ortho-Clinical Diagnostics, Inc. Antibodies to olanzapine and use thereof
WO2014031656A1 (en) 2012-08-21 2014-02-27 Ortho-Clinical Diagnostics, Inc Antibodies to olanzapine haptens and use thereof
JP2015529199A (ja) 2012-08-21 2015-10-05 オルソ−クリニカル ダイアグノスティクス，インコーポレイティド パリペリドンハプテンに対する抗体及びその使用
PL2888592T3 (pl) 2012-08-21 2018-03-30 Janssen Pharmaceutica Nv Przeciwciała względem kwetiapiny i ich zastosowania
ES2691092T3 (es) 2012-08-21 2018-11-23 Janssen Pharmaceutica Nv Anticuerpos contra la risperidona y uso de los mismos
EP2888284B1 (en) 2012-08-21 2022-07-06 Janssen Pharmaceutica NV Antibodies to risperidone haptens and use thereof
WO2014091297A1 (en) 2012-12-14 2014-06-19 Purdue Pharma L.P. Spirocyclic morphinans and their use
US8946255B2 (en) 2012-12-28 2015-02-03 Purdue Pharma L.P. Substituted morphinans and the use thereof
KR20160043047A (ko) * 2013-08-16 2016-04-20 얀센 파마슈티카 엔.브이. N형 칼슘 채널 차단제로서의 치환된 이미다졸
US9453002B2 (en) 2013-08-16 2016-09-27 Janssen Pharmaceutica Nv Substituted imidazoles as N-type calcium channel blockers
US9299409B2 (en) * 2013-09-11 2016-03-29 Tadashi Miyakawa Semiconductor storage device
WO2015097546A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Propellane-based compounds and their use as opioid receptor modulators
US10752588B2 (en) 2014-12-19 2020-08-25 The Broad Institute, Inc. Dopamine D2 receptor ligands
WO2016100940A1 (en) 2014-12-19 2016-06-23 The Broad Institute, Inc. Dopamine d2 receptor ligands
KR20170025848A (ko) 2015-08-31 2017-03-08 한국건설생활환경시험연구원 교류 직결형 엘이디 램프 결합 구조
KR20180093930A (ko) 2015-12-14 2018-08-22 트레베나, 인코포레이티드. 통각과민증을 치료하는 방법
US10435478B2 (en) 2015-12-17 2019-10-08 Janssen Pharmaceutica Nv Antibodies to quetiapine and use thereof
EP3390449A1 (en) 2015-12-17 2018-10-24 Janssen Pharmaceutica N.V. Antibodies to risperidone and use thereof
WO2023011422A1 (zh) * 2021-08-02 2023-02-09 上海枢境生物科技有限公司 氧杂螺环类衍生物、制备方法及其用途
CN121405620B (zh) * 2025-12-30 2026-03-20 山东佰隆医药有限公司 一种2-氰基-5-溴吡啶的合成方法

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387587A (en) 1986-12-23 1995-02-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
BR8904728A (pt) 1988-09-26 1990-05-01 Goodyear Tire & Rubber Processo para a sintese catalisada de acrilamidas n-substituidas
DE3837809A1 (de) 1988-11-08 1990-05-10 Merck Patent Gmbh Tetralinderivate
ATE120459T1 (de) 1988-12-13 1995-04-15 Beecham Group Plc Benzopyran und verwandte verbindungen.
EP0401958B1 (en) 1989-06-05 1995-01-11 Tokuyama Corporation Photochromic compound, composition and use thereof
CA2026389A1 (en) 1989-09-29 1991-03-30 Hideo Nakai Chromene or thiochromene derivatives, process for preparing the same and intermediate therefor
JP2985322B2 (ja) 1991-03-01 1999-11-29 東レ株式会社 イソキノリン誘導体およびその医薬用途
US5354863A (en) 1992-01-21 1994-10-11 G. D. Searle & Co. Opioid agonist compounds
GB9202238D0 (en) 1992-02-03 1992-03-18 Wellcome Found Compounds
GB9203596D0 (en) 1992-02-20 1992-04-08 Smithkline Beecham Plc Novel process
GB9207400D0 (en) 1992-04-02 1992-05-13 Smithkline Beecham Plc Novel use
CA2100514C (en) 1992-07-29 2005-03-29 Johannes A. M. Hamersma 17-spiromethylene steroids
ES2064228B1 (es) 1992-10-19 1995-09-01 Uriach & Cia Sa J Nuevas tetralonas con actividad farmacologica, composiciones que las contienen y procedimiento para su preparacion.
CA2154569A1 (en) * 1993-01-28 1994-08-04 Jeffrey J. Hale Spiro-substituted azacycles as tachykinin receptor antagonists
US6031115A (en) 1993-05-14 2000-02-29 Smithkline Beecham Plc Process for preparing epoxides
JPH09505030A (ja) 1993-08-06 1997-05-20 スミスクライン・ビーチャム・ソシエタ・ペル・アチオニ ヒドロイソキノリン誘導体
US5403846A (en) 1993-11-22 1995-04-04 Merck & Co., Inc. Spirocycles
CA2189634A1 (en) * 1994-05-06 1995-11-16 John J. Baldwin Combinatorial dihydrobenzopyran library
SE9401727D0 (sv) 1994-05-18 1994-05-18 Astra Ab New compounds I
US5683628A (en) 1994-10-17 1997-11-04 Seiko Epson Corp. Photochromic composition and photochromic resin obtainable by using the same
US5628935A (en) 1994-10-28 1997-05-13 Vision-Ease Lens, Inc. Photochromic spironaphthopyran compounds
WO1996022276A1 (en) 1995-01-20 1996-07-25 Nippon Shinyaku Co., Ltd. Ethylamine derivatives and drugs
US5656420A (en) 1995-02-24 1997-08-12 University Of Kentucky Research Foundation Method for employing the delta opioid dadle to extend tissue survival time during ischemia
IT1307327B1 (it) 1995-09-12 2001-10-30 Smithkline Beecham Spa Derivati idroisochinolinici sostituiti
JPH09301973A (ja) 1996-05-09 1997-11-25 Kumiai Chem Ind Co Ltd クロメン誘導体及びこれを有効成分とする除草剤
US5786378A (en) 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US6218424B1 (en) 1996-09-25 2001-04-17 Gpi Nil Holdings, Inc. Heterocyclic ketone and thioester compounds and uses
TW548271B (en) 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
DE19805370A1 (de) * 1997-03-14 1998-09-17 Gruenenthal Gmbh Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen
US6103722A (en) 1997-07-23 2000-08-15 The Medical College Of Wisconsin Research Foundation Inc. Ischemic preconditioning
DK1037880T3 (da) 1997-12-11 2004-11-15 Janssen Pharmaceutica Nv Anilider som retinsyremimetika
GB9804734D0 (en) 1998-03-05 1998-04-29 Pfizer Ltd Compounds
US6436959B1 (en) 1998-12-23 2002-08-20 Ortho-Mcneil Pharmaceutical, Inc. 4-[aryl(piperidin-4-yl)]aminobenzamides
FR2787789B1 (fr) 1998-12-29 2002-06-14 Lipha Benzopyranes et benzoxepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparations
TWI243173B (en) 1999-11-17 2005-11-11 Akzo Nobel Nv Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
JP2005231995A (ja) 1999-12-22 2005-09-02 Meiji Seika Kaisha Ltd オピオイドδ受容体アゴニスト／アンタゴニストとして有用なスピロ化合物
JP4275288B2 (ja) 2000-03-31 2009-06-10 新明和工業株式会社 ダンプ車輌の油圧制御装置
KR20020093966A (ko) * 2000-04-27 2002-12-16 바실리어 파마슈티카 아게 항균제로서의 크로메닐메틸 피리미딘디아민
US20010036949A1 (en) 2000-05-09 2001-11-01 Coe Jotham Wadsworth Pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal
GB0011426D0 (en) 2000-05-11 2000-06-28 Charteris Limited A method for transforming documents written in different XML-based languages
KR20020012346A (ko) 2000-08-07 2002-02-16 유현식 신디오탁틱 폴리스티렌을 고수율로 제조하고 반응기부착물을 감소시키는 담지촉매
WO2002048122A2 (en) 2000-12-14 2002-06-20 Ortho-Mcneil Pharmaceutical, Inc. Benzamidine derivatives
SE0101765D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101767D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101770D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101766D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101773D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101769D0 (sv) * 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101768D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101771D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
PT1395567E (pt) 2001-05-18 2009-03-26 Astrazeneca Ab Derivados de 4(fenil-piperazinil-metil)benzamida e sua utilização para o tratamento da ansiedade da dor ou de distúrbios gastrointestinais
EP1279666A1 (en) 2001-07-24 2003-01-29 Pfizer Products Inc. 1-diphenylmethyl-pyrazole derivatives as opioid receptor ligands
SE0103313D0 (sv) 2001-10-03 2001-10-03 Astrazeneca Ab Novel compounds
EA006507B1 (ru) 2001-10-15 2005-12-29 Янссен Фармацевтика Н.В. Новые замещенные 4-фенил-4-[1h-имидазол-2-ил] пиперидиновые производные и их применение в качестве селективных непептидных агонистов дельта-опиоидов
CN1596113B (zh) 2001-10-29 2010-05-26 蒙特库克生物科学公司 δ受体激动剂化合物在制备治疗抑郁症的药物中的应用
US6715527B2 (en) * 2001-12-11 2004-04-06 Raymond V. Ardoin Ventilation apparatus for garages
EP1469850B1 (en) 2002-01-02 2013-01-02 Versi Group, LLC Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
US7164021B2 (en) 2002-09-18 2007-01-16 The Curators Of The University Of Missouri Opiate analogs selective for the δ-opioid receptor
ES2300626T3 (es) 2002-10-15 2008-06-16 Janssen Pharmaceutica Nv Compuestos de aminoquinuclidina sustituida y su uso como ligandos del receptor delta-opioide.
WO2004035541A1 (en) 2002-10-15 2004-04-29 Janssen Pharmaceutica, N.V. Benzyl substituted (piperidin-4-yl) aminobenzamido derivatives as delta-opiod receptor modulators
SE0203302D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203301D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
US7314880B2 (en) 2003-01-02 2008-01-01 Mount Cook Biosciences, Inc. Cardioprotective delta opioid receptor agonists and methods of using same
SE0300104D0 (sv) 2003-01-16 2003-01-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0300103D0 (sv) 2003-01-16 2003-01-16 Astrazeneca Ab Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
SE0300105D0 (sv) 2003-01-16 2003-01-16 Astrazeneca Ab Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
WO2005019157A1 (en) 2003-08-15 2005-03-03 Patel Hasmukh B Choline esters useful for the treatment of cognitive dysfunctions and enhancement of memory, learning and cognition
NZ546834A (en) * 2003-10-01 2010-03-26 Adolor Corp Spirocyclic heterocyclic derivatives and methods of their use
US7598261B2 (en) * 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7576207B2 (en) * 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
WO2008033299A2 (en) * 2006-09-12 2008-03-20 Adolor Corporation Use of n-containing spirocompounds for the enhancement of cognitive function

Similar Documents

Publication Publication Date Title
JP2007507532A5 (https=)
JP2014528601A5 (https=)
JP2021524958A5 (https=)
JP2008523153A5 (https=)
JP2008508189A5 (https=)
JP2008530345A5 (https=)
JP2012504317A5 (https=)
JP2014525291A5 (https=)
NO20082387L (no) Kompetitive domene-antistofformater som binder interleukin 1 reseptor type 1
FR2918311B1 (fr) Document de securite en forme de livret, avec une page additionnelle de revelation d'une information cachee
JP2022510882A5 (https=)
WO2006071740A3 (en) 5ht2c receptor modulator compositions and methods of use
WO2006113017A3 (en) Retention of information about digital-media rights in transformed digital media content
DE602006001365D1 (de) Kristallinform beta-d von Ivabradine-hydrochlorid, Verfahren zu dessen Herstellung und diesen enthaltende Pharmazeutische Zusammensetzung
CY1109956T1 (el) Στερεα φαρμακευτικη συνθεση περιλαμβανουσα υδροχλωρικη ντονεπεζιλη
JP2023502438A5 (https=)
JP2014533241A5 (https=)
JP2022521336A5 (https=)
WO2007014137A3 (en) 8-carboxamido-substituted-2 , 6-methano-3-benzazocines and 3 - carboxamido- substituted morphanes as opioid receptor binding agents
WO2007096707A3 (en) Improved synthesis and preparations of duloxetine salts
BRPI0612189A2 (pt) composto, composiÇço farmacÊutica, mÉtodo para ligar receptores opiàides
JP2008506017A5 (https=)
JP2021502362A5 (https=)
ATE372992T1 (de) Indanyl-piperazinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
WO2008156046A1 (ja) プロジェクタ及びプロジェクタシステム